ASFV Monoclonal Antibodies
About Company
Since no vaccine or other treatments for ASF are available, highly sensitive and specific diagnostic tests are needed for early virus detection, control of viruses, and for surveillance to demonstrate freedom from disease. Creative Diagnostics have developed and characterized a panel of monoclonal antibodies against P30 and PP62, which can be applied for the detection of ASFV-specific antigens and antibodies. All of our antibodies are manufactured to the highest quality standards have been validated to work in various types of immunoassays.
Performance
Detects the early-expressed p30 structural antigen. Suitable for ELISA, IFA, IHC, IP and WB
Mab pairs available for ELISA and lateral flow assay development against P30 and PP62
Mabs recognize two distinct ASFV strains including viruses of genotype I (BA71 V) and genotype II (Georgia/2007)
High specificity and sensitivity proven